寒武纪大涨近12%逼近1400元，再创历史新高，市值超5800亿！高盛：将寒武纪目标价上调50%至1835元

Group 1 - The core viewpoint of the news is that Cambrian Biologics (寒武纪-U) experienced a significant stock price increase, reaching a historical high of 1391 yuan, with a market capitalization exceeding 580 billion yuan [1][3]. - The Ministry of Industry and Information Technology (工信部) is promoting the orderly development of computing power facilities and aims to enhance the quality of computing resource supply, particularly focusing on breakthroughs in key technologies such as GPU chips [3]. - Goldman Sachs raised the target price for Cambrian Biologics by 50% to 1835 yuan, with an optimistic scenario suggesting a potential price of 3934 yuan [3].